Literature DB >> 11169267

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.

K Bogunia-Kubik1, J Tomeczko, K Suchnicki, A Lange.   

Abstract

Determination of DRB1 and DRB3 specificities in sarcoidosis patients identified that the presence of DRB1*03 and the absence of DRB1*11 and/or DRB1*12 favors a course of disease that is associated positively with Löfgren's syndrome (DRB1*03) and negatively with stage I disease (DRB1*11 and/or 12). In common with normal controls, DRB1*03 was associated with DRB3*0101 and DRB1*11/12 with DRB3*0201/2. An analysis of DRB1 and DRB3 associations in variants of sarcoidosis revealed that DRB1*03 and DRB3*0101 were associated with Löfgren's syndrome in a combined association fashion. Conversely, a lack of DRB1*11 and/or DRB1*12 but not DRB3*0201/2 favored the clinical course of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169267     DOI: 10.1034/j.1399-0039.2001.057001087.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  16 in total

Review 1.  Genetics of sarcoidosis: candidate genes and genome scans.

Authors:  Michael C Iannuzzi; Benjamin A Rybicki
Journal:  Proc Am Thorac Soc       Date:  2007-01

Review 2.  Genetic predisposition to respiratory diseases: infiltrative lung diseases.

Authors:  Mark P Steele; Kevin K Brown
Journal:  Respiration       Date:  2007       Impact factor: 3.580

3.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

4.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.

Authors:  Hiroe Sato; Felix A Woodhead; Tariq Ahmad; Jan C Grutters; Paolo Spagnolo; Jules M M van den Bosch; Lisa A Maier; Lee S Newman; Sonoko Nagai; Takateru Izumi; Athol U Wells; Roland M du Bois; Kenneth I Welsh
Journal:  Hum Mol Genet       Date:  2010-08-03       Impact factor: 6.150

Review 5.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 6.  Granuloma genes in sarcoidosis: what is new?

Authors:  Annegret Fischer; Benjamin A Rybicki
Journal:  Curr Opin Pulm Med       Date:  2015-09       Impact factor: 3.155

7.  Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.

Authors:  Albert M Levin; Indra Adrianto; Indrani Datta; Michael C Iannuzzi; Sheri Trudeau; Jia Li; Wonder P Drake; Courtney G Montgomery; Benjamin A Rybicki
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

8.  The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles.

Authors:  Shaodong Dai; Frances Crawford; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

9.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

Review 10.  Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Authors:  David R Moller; Ben A Rybicki; Nabeel Y Hamzeh; Courtney G Montgomery; Edward S Chen; Wonder Drake; Andrew P Fontenot
Journal:  Ann Am Thorac Soc       Date:  2017-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.